Clinically 0 10 0 10 O
significant 11 22 11 22 O
cardiovascular 23 37 23 37 B-chronic_disease
disease 38 45 38 45 I-chronic_disease

Concurrent 0 10 46 56 O
use 11 14 57 60 O
of 15 17 61 63 O
other 18 23 64 69 B-treatment
anti 24 28 70 74 I-treatment
- 28 29 74 75 I-treatment
cancer 29 35 75 81 I-treatment
agents 36 42 82 88 I-treatment
or 43 45 89 91 O
treatments 46 56 92 102 B-treatment

Concurrent 0 10 103 113 O
use 11 14 114 117 O
of 15 17 118 120 O
other 18 23 121 126 O
antiandrogens 24 37 127 140 B-treatment
, 37 38 140 141 O
estrogen 39 47 142 150 B-treatment
- 47 48 150 151 I-treatment
like 48 52 151 155 I-treatment
agents 53 59 156 162 I-treatment
, 59 60 162 163 O
or 61 63 164 166 O
5a 64 66 167 169 B-treatment
- 66 67 169 170 I-treatment
reductase 67 76 170 179 I-treatment
inhibitors 77 87 180 190 I-treatment

Congestive 0 10 191 201 B-chronic_disease
heart 11 16 202 207 I-chronic_disease
failure 17 24 208 215 I-chronic_disease
( 25 26 216 217 O
within 26 32 217 223 O
certain 33 40 224 231 O
ranges 41 47 232 238 O
) 47 48 238 239 O

Currently 0 9 240 249 O
active 10 16 250 256 O
second 17 23 257 263 O
malignancy 24 34 264 274 B-cancer

History 0 7 275 282 O
of 8 10 283 285 O
Mobitz 11 17 286 292 B-chronic_disease
II 18 20 293 295 I-chronic_disease
second 21 27 296 302 I-chronic_disease
degree 28 34 303 309 I-chronic_disease
or 35 37 310 312 O
third 38 43 313 318 B-chronic_disease
degree 44 50 319 325 I-chronic_disease
heart 51 56 326 331 I-chronic_disease
block 57 62 332 337 I-chronic_disease
without 63 70 338 345 O
a 71 72 346 347 O
permanent 73 82 348 357 O
pacemaker 83 92 358 367 O
in 93 95 368 370 O
place 96 101 371 376 O

History 0 7 377 384 O
of 8 10 385 387 O
clinically 11 21 388 398 O
significant 22 33 399 410 O
ventricular 34 45 411 422 B-chronic_disease
arrhythmias 46 57 423 434 I-chronic_disease

History 0 7 435 442 O
of 8 10 443 445 O
seizure 11 18 446 453 B-chronic_disease
or 19 21 454 456 O
any 22 25 457 460 O
condition 26 35 461 470 O
that 36 40 471 475 O
may 41 44 476 479 O
predispose 45 55 480 490 B-treatment
to 56 58 491 493 O
seizure 59 66 494 501 O
including 67 76 502 511 O
, 76 77 511 512 O
but 78 81 513 516 O
not 82 85 517 520 O
limited 86 93 521 528 O
to 94 96 529 531 O
underlying 97 107 532 542 O
brain 108 113 543 548 O
injury 114 120 549 555 O
, 120 121 555 556 O
stroke 122 128 557 563 B-chronic_disease
, 128 129 563 564 O
primary 130 137 565 572 B-cancer
brain 138 143 573 578 I-cancer
tumors 144 150 579 585 I-cancer
, 150 151 585 586 O
brain 152 157 587 592 B-cancer
metastases 158 168 593 603 I-cancer
, 168 169 603 604 O
or 170 172 605 607 O
alcoholism 173 183 608 618 O

Males 0 5 619 624 B-gender

Medications 0 11 625 636 B-treatment
which 12 17 637 642 O
lowers 18 24 643 649 O
seizure 25 32 650 657 B-chronic_disease
threshold 33 42 658 667 O

Myocardial 0 10 668 678 B-chronic_disease
infarction 11 21 679 689 I-chronic_disease
within 22 28 690 696 O
6 29 30 697 698 B-upper_bound
months 31 37 699 705 I-upper_bound
of 38 40 706 708 O
Screening 41 50 709 718 O
visit 51 56 719 724 O

Patients 0 8 725 733 O
must 9 13 734 738 O
be 14 16 739 741 O
disease 17 24 742 749 O
- 24 25 749 750 O
free 25 29 750 754 O
from 30 34 755 759 O
prior 35 40 760 765 O
malignancies 41 53 766 778 B-cancer
for 54 57 779 782 O
greater 58 65 783 790 O
than 66 70 791 795 O
3 71 72 796 797 B-lower_bound
years 73 78 798 803 I-lower_bound

Patients 0 8 804 812 O
must 9 13 813 817 O
have 14 18 818 822 O
Eastern 19 26 823 830 B-clinical_variable
Cooperative 27 38 831 842 I-clinical_variable
Oncology 39 47 843 851 I-clinical_variable
Group 48 53 852 857 I-clinical_variable
( 54 55 858 859 I-clinical_variable
ECOG)performance 55 71 859 875 I-clinical_variable
status 72 78 876 882 I-clinical_variable
of 79 81 883 885 O
0 82 83 886 887 B-lower_bound
- 83 84 887 888 O
1 84 85 888 889 B-upper_bound

Patients 0 8 890 898 O
must 9 13 899 903 O
have 14 18 904 908 O
PSA 19 22 909 912 B-treatment
within 23 29 913 919 O
study 30 35 920 925 O
range 36 41 926 931 O

Patients 0 8 932 940 O
must 9 13 941 945 O
have 14 18 946 950 O
adenocarcinoma 19 33 951 965 B-cancer
of 34 36 966 968 O
the 37 40 969 972 O
prostate 41 49 973 981 O
gland 50 55 982 987 O

Patients 0 8 988 996 O
must 9 13 997 1001 O
have 14 18 1002 1006 O
evidence 19 27 1007 1015 O
of 28 30 1016 1018 O
biochemical 31 42 1019 1030 O
( 43 44 1031 1032 O
PSA 44 47 1032 1035 B-clinical_variable
) 47 48 1035 1036 O
relapse 49 56 1037 1044 O
after 57 62 1045 1050 O
prostatectomy 63 76 1051 1064 B-treatment

Patients 0 8 1065 1073 O
must 9 13 1074 1078 O
have 14 18 1079 1083 O
had 19 22 1084 1087 O
node 23 27 1088 1092 B-cancer
negative 28 36 1093 1101 I-cancer
( 37 38 1102 1103 I-cancer
pN0 38 41 1103 1106 I-cancer
) 41 42 1106 1107 I-cancer
disease 43 50 1108 1115 I-cancer
found 51 56 1116 1121 O
at 57 59 1122 1124 O
the 60 63 1125 1128 O
time 64 68 1129 1133 O
of 69 71 1134 1136 O
surgery 72 79 1137 1144 B-treatment

Patients 0 8 1145 1153 O
must 9 13 1154 1158 O
have 14 18 1159 1163 O
non 19 22 1164 1167 B-cancer
- 22 23 1167 1168 I-cancer
metastatic 23 33 1168 1178 I-cancer
( 34 35 1179 1180 I-cancer
M0 35 37 1180 1182 I-cancer
) 37 38 1182 1183 I-cancer
disease 39 46 1184 1191 I-cancer
, 46 47 1191 1192 O
as 48 50 1193 1195 O
defined 51 58 1196 1203 O
by 59 61 1204 1206 O
a 62 63 1207 1208 O
lack 64 68 1209 1213 O
of 69 71 1214 1216 O
metastases 72 82 1217 1227 B-cancer
seen 83 87 1228 1232 O
on 88 90 1233 1235 O
CT 91 93 1236 1238 B-treatment
scan 94 98 1239 1243 I-treatment
of 99 101 1244 1246 O
the 102 105 1247 1250 O
chest 106 111 1251 1256 O
/ 111 112 1256 1257 O
abdomen 112 119 1257 1264 O
/ 119 120 1264 1265 O
pelvis 120 126 1265 1271 O
and 127 130 1272 1275 O
whole 131 136 1276 1281 O
- 136 137 1281 1282 O
body 137 141 1282 1286 O
radionuclide 142 154 1287 1299 O
99Technetium 155 167 1300 1312 O
( 168 169 1313 1314 O
Tc 169 171 1314 1316 O
) 171 172 1316 1317 O
bone 173 177 1318 1322 B-treatment
scan 178 182 1323 1327 I-treatment
, 182 183 1327 1328 O
( 184 185 1329 1330 O
or 185 187 1330 1332 O
sodium 188 194 1333 1339 B-treatment
fluoride 195 203 1340 1348 I-treatment
PET 204 207 1349 1352 I-treatment
scan 208 212 1353 1357 I-treatment
) 212 213 1357 1358 O
taken 214 219 1359 1364 O
within 220 226 1365 1371 O
3 227 228 1372 1373 B-upper_bound
months 229 235 1374 1380 I-upper_bound
of 236 238 1381 1383 O
study 239 244 1384 1389 O
entry 245 250 1390 1395 O

Patients 0 8 1396 1404 O
must 9 13 1405 1409 O
have 14 18 1410 1414 O
received 19 27 1415 1423 O
primary 28 35 1424 1431 O
treatment 36 45 1432 1441 B-treatment
with 46 50 1442 1446 O
radical 51 58 1447 1454 B-treatment
prostatectomy 59 72 1455 1468 I-treatment

Patients 0 8 1469 1477 O
must 9 13 1478 1482 O
have 14 18 1483 1487 O
the 19 22 1488 1491 O
ability 23 30 1492 1499 O
to 31 33 1500 1502 O
swallow 34 41 1503 1510 O
the 42 45 1511 1514 O
study 46 51 1515 1520 B-treatment
drug 52 56 1521 1525 I-treatment
whole 57 62 1526 1531 O
as 63 65 1532 1534 O
a 66 67 1535 1536 O
tablet 68 74 1537 1543 O
or 75 77 1544 1546 O
capsule 78 85 1547 1554 O

Patients 0 8 1555 1563 O
must 9 13 1564 1568 O
not 14 17 1569 1572 O
have 18 22 1573 1577 O
previously 23 33 1578 1588 O
received 34 42 1589 1597 O
hormonal 43 51 1598 1606 B-treatment
therapy 52 59 1607 1614 I-treatment
( 60 61 1615 1616 O
LHRH 61 65 1616 1620 B-clinical_variable
agonist 66 73 1621 1628 O
, 73 74 1628 1629 O
antiandrogen 75 87 1630 1642 B-treatment
, 87 88 1642 1643 O
or 89 91 1644 1646 O
both 92 96 1647 1651 O
) 96 97 1651 1652 O

Patients 0 8 1653 1661 O
taking 9 15 1662 1668 O
medications 16 27 1669 1680 B-treatment
that 28 32 1681 1685 O
may 33 36 1686 1689 O
have 37 41 1690 1694 O
adverse 42 49 1695 1702 O
interactions 50 62 1703 1715 O
with 63 67 1716 1720 O
enzalutamide 68 80 1721 1733 B-treatment

Primary 0 7 1734 1741 B-treatment
treatment 8 17 1742 1751 I-treatment
with 18 22 1752 1756 I-treatment
radiation 23 32 1757 1766 I-treatment
therapy 33 40 1767 1774 I-treatment

Prolonged 0 9 1775 1784 O
corrected 10 19 1785 1794 O
QT 20 22 1795 1797 B-clinical_variable
interval 23 31 1798 1806 I-clinical_variable

Radiographic 0 12 1807 1819 O
or 13 15 1820 1822 O
clinical 16 24 1823 1831 O
evidence 25 33 1832 1840 O
of 34 36 1841 1843 O
local 37 42 1844 1849 O
- 42 43 1849 1850 O
regional 43 51 1850 1858 O
tumor 52 57 1859 1864 B-cancer
recurrence 58 68 1865 1875 O

Serious 0 7 1876 1883 O
concurrent 8 18 1884 1894 O
medical 19 26 1895 1902 B-chronic_disease
illnesses 27 36 1903 1912 I-chronic_disease
( 37 38 1913 1914 O
including 38 47 1914 1923 O
uncontrolled 48 60 1924 1936 O
major 61 66 1937 1942 O
cardiac 67 74 1943 1950 B-chronic_disease
, 74 75 1950 1951 O
pulmonary 76 85 1952 1961 B-chronic_disease
, 85 86 1961 1962 O
Child 87 92 1963 1968 B-chronic_disease
- 92 93 1968 1969 I-chronic_disease
Pugh 93 97 1969 1973 I-chronic_disease
C 98 99 1974 1975 I-chronic_disease
liver 100 105 1976 1981 I-chronic_disease
or 106 108 1982 1984 O
psychiatric 109 120 1985 1996 B-chronic_disease
diseases 121 129 1997 2005 I-chronic_disease
) 129 130 2005 2006 O
or 131 133 2007 2009 O
active 134 140 2010 2016 O
major 141 146 2017 2022 O
infections 147 157 2023 2033 B-chronic_disease
( 158 159 2034 2035 O
including 159 168 2035 2044 O
HIV 169 172 2045 2048 B-chronic_disease
, 172 173 2048 2049 O
Hepatitis 174 183 2050 2059 B-chronic_disease
A 184 185 2060 2061 I-chronic_disease
- 185 186 2061 2062 I-chronic_disease
C 186 187 2062 2063 I-chronic_disease
) 187 188 2063 2064 O

Uncontrolled 0 12 2065 2077 B-chronic_disease
angina 13 19 2078 2084 I-chronic_disease
within 20 26 2085 2091 O
3 27 28 2092 2093 B-upper_bound
months 29 35 2094 2100 I-upper_bound
of 36 38 2101 2103 O
Screening 39 48 2104 2113 O
visit 49 54 2114 2119 O

Uncontrolled 0 12 2120 2132 O
hypertension 13 25 2133 2145 B-chronic_disease
within 26 32 2146 2152 O
certain 33 40 2153 2160 O
ranges 41 47 2161 2167 O

Use 0 3 2168 2171 O
of 4 6 2172 2174 O
systemic 7 15 2175 2183 B-treatment
corticosteroids 16 31 2184 2199 I-treatment
equivalent 32 42 2200 2210 O
to 43 45 2211 2213 O
prednisone 46 56 2214 2224 B-treatment

aged 0 4 2225 2229 B-age
18 5 7 2230 2232 B-lower_bound
years 8 13 2233 2238 I-lower_bound
of 14 16 2239 2241 O
age 17 20 2242 2245 O
and 21 24 2246 2249 O
above 25 30 2250 2255 O

history 0 7 2256 2263 O
of 8 10 2264 2266 O
loss 11 15 2267 2271 B-chronic_disease
of 16 18 2272 2274 I-chronic_disease
consciousness 19 32 2275 2288 I-chronic_disease
or 33 35 2289 2291 O
transient 36 45 2292 2301 B-chronic_disease
ischemic 46 54 2302 2310 I-chronic_disease
attack 55 61 2311 2317 I-chronic_disease
within 62 68 2318 2324 O
12months 69 77 2325 2333 B-upper_bound
of 78 80 2334 2336 O
enrollment 81 91 2337 2347 O
( 92 93 2348 2349 O
Day 93 96 2349 2352 O
1 97 98 2353 2354 O
visit 99 104 2355 2360 O
) 104 105 2360 2361 O

inhaled 0 7 2362 2369 B-treatment
corticosteroids 8 23 2370 2385 I-treatment

life 0 4 2386 2390 B-clinical_variable
expectancy 5 15 2391 2401 I-clinical_variable
greater 16 23 2402 2409 O
3 24 25 2410 2411 B-lower_bound
years 26 31 2412 2417 I-lower_bound

male 0 4 2418 2422 B-gender
patient 5 12 2423 2430 I-gender
and 13 16 2431 2434 O
his 17 20 2435 2438 O
female 21 27 2439 2445 B-gender
partner 28 35 2446 2453 O
who 36 39 2454 2457 O
is 40 42 2458 2460 O
of 43 45 2461 2463 O
childbearing 46 58 2464 2476 O
potential 59 68 2477 2486 O
must 69 73 2487 2491 O
use 74 77 2492 2495 B-contraception_consent
2 78 79 2496 2497 I-contraception_consent
acceptable 80 90 2498 2508 I-contraception_consent
methods 91 98 2509 2516 I-contraception_consent
of 99 101 2517 2519 I-contraception_consent
birth 102 107 2520 2525 I-contraception_consent
control 108 115 2526 2533 I-contraception_consent
( 116 117 2534 2535 O
1 117 118 2535 2536 O
of 119 121 2537 2539 O
which 122 127 2540 2545 O
must 128 132 2546 2550 O
include 133 140 2551 2558 O
a 141 142 2559 2560 O
condom 143 149 2561 2567 B-contraception_consent
as 150 152 2568 2570 I-contraception_consent
a 153 154 2571 2572 I-contraception_consent
barrier 155 162 2573 2580 I-contraception_consent
method 163 169 2581 2587 I-contraception_consent
of 170 172 2588 2590 I-contraception_consent
contraception 173 186 2591 2604 I-contraception_consent
) 186 187 2604 2605 O
starting 188 196 2606 2614 O
at 197 199 2615 2617 O
screening 200 209 2618 2627 O
and 210 213 2628 2631 O
continuing 214 224 2632 2642 O
throughout 225 235 2643 2653 O
the 236 239 2654 2657 O
study 240 245 2658 2663 O
period 246 252 2664 2670 O
and 253 256 2671 2674 O
for 257 260 2675 2678 O
3 261 262 2679 2680 B-upper_bound
months 263 269 2681 2687 I-upper_bound
after 270 275 2688 2693 I-upper_bound
final 276 281 2694 2699 O
study 282 287 2700 2705 B-treatment
drug 288 292 2706 2710 I-treatment
administration 293 307 2711 2725 O
or 308 310 2726 2728 O
per 311 314 2729 2732 O
local 315 320 2733 2738 O
guidelines 321 331 2739 2749 O
where 332 337 2750 2755 O
these 338 343 2756 2761 O
require 344 351 2762 2769 O
additional 352 362 2770 2780 O
description 363 374 2781 2792 O
of 375 377 2793 2795 O
contraceptive 378 391 2796 2809 O
methods 392 399 2810 2817 O

non 0 3 2818 2821 B-cancer
- 3 4 2821 2822 I-cancer
melanoma 4 12 2822 2830 I-cancer
skin 13 17 2831 2835 I-cancer
cancers 18 25 2836 2843 I-cancer
and 26 29 2844 2847 O
superficial 30 41 2848 2859 B-cancer
urothelial 42 52 2860 2870 I-cancer
cancers 53 60 2871 2878 I-cancer

with 0 4 2879 2883 O
the 5 8 2884 2887 O
exception 9 18 2888 2897 O
of 19 21 2898 2900 O
neoadjuvant 22 33 2901 2912 B-treatment
or 34 36 2913 2915 I-treatment
adjuvant 37 45 2916 2924 I-treatment
hormones 46 54 2925 2933 I-treatment
given 55 60 2934 2939 O
in 61 63 2940 2942 O
conjunction 64 75 2943 2954 O
with 76 80 2955 2959 O
prostatectomy 81 94 2960 2973 B-treatment

